Abstract
Bioenergetic mitochondrial dysfunction is a common feature of several diseases, including Alzheimer’s disease (AD), where redox imbalance also plays an important role in terms of disease development. AD is an age-related disease and begins many years before the appearance of neurodegenerative symptoms. Intracellular tau aggregation, extracellular β-amyloid (Aβ) deposition in the brain, and even the APOE4 genotype contribute to the process of AD by impairing redox homeostasis and mitochondrial dysfunction. This review summarizes the evidence for the redox imbalance and mitochondrial dysfunction in AD and demonstrates the current therapeutic strategies related to mitochondrial maintenance.
Original language | English |
---|---|
Article number | 1816 |
Journal | Antioxidants |
Volume | 12 |
Issue number | 10 |
DOIs | |
State | Published - 30 09 2023 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2023 by the authors.
Keywords
- APOE4
- Alzheimer’s disease
- mitochondrial dysfunctions
- redox homeostasis
- tau
- β-amyloid